L2-01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for L2-01, covering 2025-06-08 to 2025-06-08. Get the full timeline:
Most recent: Clinical Trial Update: A Double-Blind, Randomized, Placebo-Controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of L2-01 in Subjects With Crohn's Disease [Phase 2]